Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.83 Analyst target: $7.75 Upside: 833.62%
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.
See the full interactive analysis & chart →Informational only — not investment advice.